Low-dose solumatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, phase III safety study

Roy D. Altman, Vibeke Strand, Marc C. Hochberg, Allan Gibofsky, Joseph A. Markenson, William E. Hopkins, Byron Cryer, Alan Kivitz, Jennifer Nezzer, Olaolu Imasogie, Clarence L. Young

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Low-dose solumatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, phase III safety study'. Together they form a unique fingerprint.

Medicine & Life Sciences